English

CUE HEALTH INC.

EDGAR

HLTH Annual report (10-K) · filed 2024-03-13

22 filing records in this dataset, filed from 2021-09-01 to 2024-03-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

18.8 million USD

2023 Q4 · USD

Exact inputs and evidence

Revenue: 70936000 USD Source
Revenue: 52138000 USD Source

Operating margin

-792.13%

2023 Q4 · %

Exact inputs and evidence

Operating Income: -394853000 USD Source
Operating Income: -245948000 USD Source
Revenue: 70936000 USD Source
Revenue: 52138000 USD Source

Operating cash flow

-28.7 million USD

2023 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -137811000 USD Source
Operating Cash Flow: -109090000 USD Source

Free cash flow

-30.1 million USD

2023 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -137811000 USD Source
Operating Cash Flow: -109090000 USD Source
Capital Expenditure: 9169000 USD Source
Capital Expenditure: 7800000 USD Source

Cash and cash equivalents: 80.9 million USD 2023-12-31 Source
Exact value

80889000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 155 million shares 2023-12-31 Source
Exact value

155304764 shares

Reported share-count change

3.26% · 4.9 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

150406014 shares · 2022-12-31· Source
155304764 shares · 2023-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

70.9 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Revenue: 24765000 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 9896000 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 17477000 USD · 2023-07-01 – 2023-09-30 Source
Revenue: 70936000 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 52138000 USD · 2023-01-01 – 2023-09-30 Source

Net income

-373 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Net income: -94198000 USD · 2023-01-01 – 2023-03-31 Source
Net income: -83864000 USD · 2023-04-01 – 2023-06-30 Source
Net income: -46970000 USD · 2023-07-01 – 2023-09-30 Source
Net income: -373464000 USD · 2023-01-01 – 2023-12-31 Source
Net income: -225032000 USD · 2023-01-01 – 2023-09-30 Source

Operating cash flow

-138 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Operating cash flow: -53883000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -96547000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -53883000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -109090000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -96547000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -137811000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -109090000 USD · 2023-01-01 – 2023-09-30 Source

Capital expenditure

9.17 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Capital expenditure: 3906000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 6147000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 3906000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 7800000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 6147000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 9169000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 7800000 USD · 2023-01-01 – 2023-09-30 Source

Free cash flow

-147 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Operating cash flow: -53883000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -96547000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -53883000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -109090000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -96547000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -137811000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -109090000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 3906000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 6147000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 3906000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 7800000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 6147000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 9169000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 7800000 USD · 2023-01-01 – 2023-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-03-13.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2023-12-31
Operating income: 5 of 11 periods available· newest 2023-12-31
Net income: 5 of 11 periods available· newest 2023-12-31
Operating cash flow: 5 of 11 periods available· newest 2023-12-31
Capital expenditure: 5 of 11 periods available· newest 2023-12-31
Total assets: 4 of 11 periods available· newest 2023-12-31
Total liabilities: 4 of 11 periods available· newest 2023-12-31
Current assets: 4 of 11 periods available· newest 2023-12-31
Current liabilities: 4 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2023-12-31
long term debt: No compatible figures in this window
Shares outstanding: 4 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-85.3%

Prior period

USD 483.48 million

2022-01-01 – 2022-12-31
Current period

USD 70.94 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

70936000 − 483476000 = -412540000 USD

483476000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
70936000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CUE HEALTH INC. · 2023-12-31 CUE HEALTH INC. (edgar:1628945) Year-over-year change in Revenue: -412540000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 70936000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1154373 Filing: 000162894524000048 Input fundies:Revenue: 483476000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1155028 Filing: 000162894524000048
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 179.41 million

Prior period

−USD 194.06 million

2022-01-01 – 2022-12-31
Current period

−USD 373.46 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-373464000 − -194056000 = -179408000 USD

-194056000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-373464000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CUE HEALTH INC. · 2023-12-31 CUE HEALTH INC. (edgar:1628945) Year-over-year change in Net income: -179408000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -373464000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#2078118 Filing: 000162894524000048 Input fundies:NetIncome: -194056000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#2078821 Filing: 000162894524000048
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 25.89 million

Prior period

−USD 111.92 million

2022-01-01 – 2022-12-31
Current period

−USD 137.81 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-137811000 − -111919000 = -25892000 USD

-111919000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-137811000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CUE HEALTH INC. · 2023-12-31 CUE HEALTH INC. (edgar:1628945) Year-over-year change in Operating cash flow: -25892000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -137811000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1392625 Filing: 000162894524000048 Input fundies:OperatingCashFlow: -111919000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1393283 Filing: 000162894524000048
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-81.7%

Prior period

USD 50.18 million

2022-01-01 – 2022-12-31
Current period

USD 9.17 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

9169000 − 50181000 = -41012000 USD

50181000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
9169000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CUE HEALTH INC. · 2023-12-31 CUE HEALTH INC. (edgar:1628945) Year-over-year change in Capital expenditure: -41012000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 9169000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1395481 Filing: 000162894524000048 Input fundies:CapitalExpenditure: 50181000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1396076 Filing: 000162894524000048
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 70.94 million 100% of revenue
Operating costs Derived USD 465.79 million 657% of revenue
Operating income −USD 394.85 million −557% of revenue
Tax, interest and other Derived −USD 21.39 million −30% of revenue
Net income −USD 373.46 million −526% of revenue

Cash

Operating cash flow −USD 137.81 million −194% of revenue
Capital expenditure USD 9.17 million 13% of revenue
Free cash flow Derived −USD 146.98 million −207% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Operating loss: operating costs were 413% of revenue.
2020 Operating loss: operating costs were 297% of revenue.
2021 14%17%69%
2022 Operating loss: operating costs were 143% of revenue.
2023 Operating loss: operating costs were 657% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	6626000	27393000 Derived	-20767000	-161000 Derived	-20606000	-15941000 Derived	Source 2019-01-01 – 2019-12-31: 6626000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -20767000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -20606000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -12996000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 2945000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	22953000	68079000 Derived	-45126000	2226000 Derived	-47352000	16621000 Derived	Source 2020-01-01 – 2020-12-31: 22953000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -45126000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -47352000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 92655000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 76034000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	618107000	427888000 Derived	190219000	103801000 Derived	86418000	-118297000 Derived	Source 2021-01-01 – 2021-12-31: 618107000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 190219000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 86418000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -9449000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 108848000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	483476000	689128000 Derived	-205652000	-11596000 Derived	-194056000	-162100000 Derived	Source 2022-01-01 – 2022-12-31: 483476000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -205652000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -194056000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -111919000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 50181000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	70936000	465789000 Derived	-394853000	-21389000 Derived	-373464000	-146980000 Derived	Source 2023-01-01 – 2023-12-31: 70936000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -394853000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -373464000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -137811000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 9169000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 70.9M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Revenue	6626000	Revenue: 6626000 Open source
20202020-12-31	Revenue	22953000	Revenue: 22953000 Open source
20212021-12-31	Revenue	618107000	Revenue: 618107000 Open source
20222022-12-31	Revenue	483476000	Revenue: 483476000 Open source
20232023-12-31	Revenue	70936000	Revenue: 70936000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-85.3% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 6626000 Open source
20202020-12-31	Year over year	246.4%	Revenue: 22953000 Open source Revenue: 6626000 Open source
20212021-12-31	Year over year	2,592.9%	Revenue: 618107000 Open source Revenue: 22953000 Open source
20222022-12-31	Year over year	-21.8%	Revenue: 483476000 Open source Revenue: 618107000 Open source
20232023-12-31	Year over year	-85.3%	Revenue: 70936000 Open source Revenue: 483476000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -556.6% 2023

Net margin -526.5% 2023

Free cash flow margin -207.2% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	-313.4%	Operating Income: -20767000 Open source Revenue: 6626000 Open source
20202020-12-31	Operating margin	-196.6%	Operating Income: -45126000 Open source Revenue: 22953000 Open source
20212021-12-31	Operating margin	30.8%	Operating Income: 190219000 Open source Revenue: 618107000 Open source
20222022-12-31	Operating margin	-42.5%	Operating Income: -205652000 Open source Revenue: 483476000 Open source
20232023-12-31	Operating margin	-556.6%	Operating Income: -394853000 Open source Revenue: 70936000 Open source
20192019-12-31	Net margin	-311%	Net Income: -20606000 Open source Revenue: 6626000 Open source
20202020-12-31	Net margin	-206.3%	Net Income: -47352000 Open source Revenue: 22953000 Open source
20212021-12-31	Net margin	14%	Net Income: 86418000 Open source Revenue: 618107000 Open source
20222022-12-31	Net margin	-40.1%	Net Income: -194056000 Open source Revenue: 483476000 Open source
20232023-12-31	Net margin	-526.5%	Net Income: -373464000 Open source Revenue: 70936000 Open source
20192019-12-31	Free cash flow margin	-240.6%	Revenue: 6626000 Open source Operating Cash Flow: -12996000 Open source Capital Expenditure: 2945000 Open source
20202020-12-31	Free cash flow margin	72.4%	Revenue: 22953000 Open source Operating Cash Flow: 92655000 Open source Capital Expenditure: 76034000 Open source
20212021-12-31	Free cash flow margin	-19.1%	Revenue: 618107000 Open source Operating Cash Flow: -9449000 Open source Capital Expenditure: 108848000 Open source
20222022-12-31	Free cash flow margin	-33.5%	Revenue: 483476000 Open source Operating Cash Flow: -111919000 Open source Capital Expenditure: 50181000 Open source
20232023-12-31	Free cash flow margin	-207.2%	Revenue: 70936000 Open source Operating Cash Flow: -137811000 Open source Capital Expenditure: 9169000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -137.8M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Operating cash flow	-12996000	Operating Cash Flow: -12996000 Open source
20202020-12-31	Operating cash flow	92655000	Operating Cash Flow: 92655000 Open source
20212021-12-31	Operating cash flow	-9449000	Operating Cash Flow: -9449000 Open source
20222022-12-31	Operating cash flow	-111919000	Operating Cash Flow: -111919000 Open source
20232023-12-31	Operating cash flow	-137811000	Operating Cash Flow: -137811000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -147M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Free cash flow	-15941000	Operating Cash Flow: -12996000 Open source Capital Expenditure: 2945000 Open source
20202020-12-31	Free cash flow	16621000	Operating Cash Flow: 92655000 Open source Capital Expenditure: 76034000 Open source
20212021-12-31	Free cash flow	-118297000	Operating Cash Flow: -9449000 Open source Capital Expenditure: 108848000 Open source
20222022-12-31	Free cash flow	-162100000	Operating Cash Flow: -111919000 Open source Capital Expenditure: 50181000 Open source
20232023-12-31	Free cash flow	-146980000	Operating Cash Flow: -137811000 Open source Capital Expenditure: 9169000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

26.4% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2019-12-31	Liabilities / assets	Not reported	No source recorded
20202020-12-31	Liabilities / assets	76.3%	Total Liabilities: 241405000 Open source Total Assets: 316328000 Open source
20212021-12-31	Liabilities / assets	24.8%	Total Liabilities: 233310000 Open source Total Assets: 940060000 Open source
20222022-12-31	Liabilities / assets	17%	Total Liabilities: 118086000 Open source Total Assets: 694580000 Open source
20232023-12-31	Liabilities / assets	26.4%	Total Liabilities: 89535000 Open source Total Assets: 339787000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.54× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2019-12-31	Current assets / current liabilities	Not reported	No source recorded
20202020-12-31	Current assets / current liabilities	1.18×	Current Assets: 183698000 Open source Current Liabilities: 155896000 Open source
20212021-12-31	Current assets / current liabilities	4.01×	Current Assets: 670022000 Open source Current Liabilities: 166936000 Open source
20222022-12-31	Current assets / current liabilities	5.21×	Current Assets: 371153000 Open source Current Liabilities: 71195000 Open source
20232023-12-31	Current assets / current liabilities	2.54×	Current Assets: 110362000 Open source Current Liabilities: 43466000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−USD 20.61 million Exact value Exact value: -20606000 USD 2019-01-01 – 2019-12-31: -20606000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUE HEALTH INC. · 2019-12-31 CUE HEALTH INC. (edgar:1628945) Net Income: -20606000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20606000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894522000031/hlth-20211231.htm#2541915 Filing: 000162894522000031 The citation records this snapshot. The page link may show a newer release later.	−USD 13 million Exact value Exact value: -12996000 USD 2019-01-01 – 2019-12-31: -12996000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CUE HEALTH INC. · 2019-12-31 CUE HEALTH INC. (edgar:1628945) Operating Cash Flow: -12996000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12996000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894522000031/hlth-20211231.htm#1742315 Filing: 000162894522000031 The citation records this snapshot. The page link may show a newer release later.	USD 2.95 million Exact value Exact value: 2945000 USD 2019-01-01 – 2019-12-31: 2945000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CUE HEALTH INC. · 2019-12-31 CUE HEALTH INC. (edgar:1628945) Capital Expenditure: 2945000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2945000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894522000031/hlth-20211231.htm#1746754 Filing: 000162894522000031 The citation records this snapshot. The page link may show a newer release later.	−USD 15.94 million Calculation and evidence -12996000 − 2945000 USD Exact free cash flow: -15941000 USD 2019-01-01 – 2019-12-31: -12996000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 2945000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CUE HEALTH INC. · 2019-12-31 CUE HEALTH INC. (edgar:1628945) Free cash flow: -15941000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12996000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894522000031/hlth-20211231.htm#1742315 Filing: 000162894522000031 Input fundies:CapitalExpenditure: 2945000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894522000031/hlth-20211231.htm#1746754 Filing: 000162894522000031 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 47.35 million Exact value Exact value: -47352000 USD 2020-01-01 – 2020-12-31: -47352000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUE HEALTH INC. · 2020-12-31 CUE HEALTH INC. (edgar:1628945) Net Income: -47352000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47352000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894523000063/hlth-20221231.htm#2142665 Filing: 000162894523000063 The citation records this snapshot. The page link may show a newer release later.	USD 92.66 million Exact value Exact value: 92655000 USD 2020-01-01 – 2020-12-31: 92655000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CUE HEALTH INC. · 2020-12-31 CUE HEALTH INC. (edgar:1628945) Operating Cash Flow: 92655000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 92655000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894523000063/hlth-20221231.htm#1451151 Filing: 000162894523000063 The citation records this snapshot. The page link may show a newer release later.	USD 76.03 million Exact value Exact value: 76034000 USD 2020-01-01 – 2020-12-31: 76034000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CUE HEALTH INC. · 2020-12-31 CUE HEALTH INC. (edgar:1628945) Capital Expenditure: 76034000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 76034000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894523000063/hlth-20221231.htm#1454066 Filing: 000162894523000063 The citation records this snapshot. The page link may show a newer release later.	USD 16.62 million Calculation and evidence 92655000 − 76034000 USD Exact free cash flow: 16621000 USD 2020-01-01 – 2020-12-31: 92655000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 76034000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CUE HEALTH INC. · 2020-12-31 CUE HEALTH INC. (edgar:1628945) Free cash flow: 16621000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 92655000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894523000063/hlth-20221231.htm#1451151 Filing: 000162894523000063 Input fundies:CapitalExpenditure: 76034000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894523000063/hlth-20221231.htm#1454066 Filing: 000162894523000063 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 86.42 million Exact value Exact value: 86418000 USD 2021-01-01 – 2021-12-31: 86418000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUE HEALTH INC. · 2021-12-31 CUE HEALTH INC. (edgar:1628945) Net Income: 86418000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 86418000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#2079524 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.	−USD 9.45 million Exact value Exact value: -9449000 USD 2021-01-01 – 2021-12-31: -9449000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CUE HEALTH INC. · 2021-12-31 CUE HEALTH INC. (edgar:1628945) Operating Cash Flow: -9449000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9449000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1393942 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.	USD 108.85 million Exact value Exact value: 108848000 USD 2021-01-01 – 2021-12-31: 108848000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CUE HEALTH INC. · 2021-12-31 CUE HEALTH INC. (edgar:1628945) Capital Expenditure: 108848000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 108848000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1396673 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.	−USD 118.3 million Calculation and evidence -9449000 − 108848000 USD Exact free cash flow: -118297000 USD 2021-01-01 – 2021-12-31: -9449000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 108848000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CUE HEALTH INC. · 2021-12-31 CUE HEALTH INC. (edgar:1628945) Free cash flow: -118297000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9449000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1393942 Filing: 000162894524000048 Input fundies:CapitalExpenditure: 108848000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1396673 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 194.06 million Exact value Exact value: -194056000 USD 2022-01-01 – 2022-12-31: -194056000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUE HEALTH INC. · 2022-12-31 CUE HEALTH INC. (edgar:1628945) Net Income: -194056000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -194056000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#2078821 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.	−USD 111.92 million Exact value Exact value: -111919000 USD 2022-01-01 – 2022-12-31: -111919000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CUE HEALTH INC. · 2022-12-31 CUE HEALTH INC. (edgar:1628945) Operating Cash Flow: -111919000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -111919000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1393283 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.	USD 50.18 million Exact value Exact value: 50181000 USD 2022-01-01 – 2022-12-31: 50181000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CUE HEALTH INC. · 2022-12-31 CUE HEALTH INC. (edgar:1628945) Capital Expenditure: 50181000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 50181000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1396076 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.	−USD 162.1 million Calculation and evidence -111919000 − 50181000 USD Exact free cash flow: -162100000 USD 2022-01-01 – 2022-12-31: -111919000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 50181000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CUE HEALTH INC. · 2022-12-31 CUE HEALTH INC. (edgar:1628945) Free cash flow: -162100000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -111919000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1393283 Filing: 000162894524000048 Input fundies:CapitalExpenditure: 50181000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1396076 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 373.46 million Exact value Exact value: -373464000 USD 2023-01-01 – 2023-12-31: -373464000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CUE HEALTH INC. · 2023-12-31 CUE HEALTH INC. (edgar:1628945) Net Income: -373464000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -373464000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#2078118 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.	−USD 137.81 million Exact value Exact value: -137811000 USD 2023-01-01 – 2023-12-31: -137811000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CUE HEALTH INC. · 2023-12-31 CUE HEALTH INC. (edgar:1628945) Operating Cash Flow: -137811000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -137811000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1392625 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.	USD 9.17 million Exact value Exact value: 9169000 USD 2023-01-01 – 2023-12-31: 9169000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CUE HEALTH INC. · 2023-12-31 CUE HEALTH INC. (edgar:1628945) Capital Expenditure: 9169000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9169000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1395481 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.	−USD 146.98 million Calculation and evidence -137811000 − 9169000 USD Exact free cash flow: -146980000 USD 2023-01-01 – 2023-12-31: -137811000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 9169000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CUE HEALTH INC. · 2023-12-31 CUE HEALTH INC. (edgar:1628945) Free cash flow: -146980000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1628945?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -137811000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1392625 Filing: 000162894524000048 Input fundies:CapitalExpenditure: 9169000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1628945/000162894524000048/hlth-20231231.htm#1395481 Filing: 000162894524000048 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

22 filings · 914 latest values · 914 originally reported values

Dataset published 2026-11-07. Source filing dates and reporting periods are shown separately.

Identifiers: 0001628945, 1628945, HLTH, edgar:1628945

Also known as CUE HEALTH INC., Cue Health Inc., Cue Inc.

CUE HEALTH INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation